Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adeno-associated vectors for targeted treatment

Recombinant adeno-associated vectors for targeted treatment

US Patent 11833226 · Granted Dec 5, 2023

Estimated economic value: $6,425,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adeno-associated virus compositions for restoring HBB gene function and methods 2025
Adeno-associated virus compositions for restoring HBB gene function and methods 2025
Adeno-associated virus compositions for restoring HBB gene function and methods 2025
System, device and method for production of bioproduct including high density ce2024
Adeno-associated virus vector variants for high efficiency genome editing and me2024
Adeno-associated virus vector variants for high efficiency genome editing and me2024
Adeno-associated virus vector variants for high efficiency genome editing and me2024
Adeno-associated virus compositions for restoring F8 gene function and methods o2024
Adeno-associated virus compositions for restoring F8 gene function and methods o2024
Adeno-associated virus vector variants for high efficiency genome editing and me2022
Adeno-associated virus vector variants for high efficiency genome editing and me2022
Adeno-associated virus vector variants for high efficiency genome editing and me2022